BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23566618)

  • 1. [Which anti-tumour benefits to be expected from metformin?].
    Beck E; Scheen AJ
    Ann Endocrinol (Paris); 2013 May; 74(2):137-47. PubMed ID: 23566618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metformin, an antidiabetic molecule with anti-cancer properties].
    Beck E; Scheen AJ
    Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-Varying Risk for Breast Cancer Following Initiation of Glucose-Lowering Therapy in Women with Type 2 Diabetes: Exploring Detection Bias.
    Bowker SL; Lin M; Eurich DT; Johnson JA
    Can J Diabetes; 2017 Apr; 41(2):204-210. PubMed ID: 27908558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-cancer activity of metformin: new perspectives for an old drug].
    Beck E; Scheen AJ
    Rev Med Suisse; 2010 Sep; 6(260):1601-7. PubMed ID: 20853715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
    Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
    Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
    Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
    Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
    Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
    Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects.
    Prescrire Int; 2014 Nov; 23(154):269-72. PubMed ID: 25954799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it time to test metformin in breast cancer clinical trials?
    Cazzaniga M; Bonanni B; Guerrieri-Gonzaga A; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):701-5. PubMed ID: 19240238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin in cancer treatment and prevention.
    Morales DR; Morris AD
    Annu Rev Med; 2015; 66():17-29. PubMed ID: 25386929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in Individuals Treated With Glucose-Lowering Agents: A Large, Controlled Cohort Study.
    Claesen M; Gillard P; De Smet F; Callens M; De Moor B; Mathieu C
    J Clin Endocrinol Metab; 2016 Feb; 101(2):461-9. PubMed ID: 26678656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of metformin in diabetes treatment--is metformin falling from grace?].
    van Dijk PR; Landman GW; Bilo HJ
    Ned Tijdschr Geneeskd; 2012; 156(43):A5297. PubMed ID: 23095485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of antidiabetic medications on the development and progression of prostate cancer.
    Hitron A; Adams V; Talbert J; Steinke D
    Cancer Epidemiol; 2012 Aug; 36(4):e243-50. PubMed ID: 22417708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case-control study based on Italian healthcare utilization databases.
    Bosetti C; Franchi M; Nicotra F; Asciutto R; Merlino L; La Vecchia C; Corrao G
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):771-8. PubMed ID: 26013675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New clinical data with metformin therapy in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin in cancer.
    Mallik R; Chowdhury TA
    Diabetes Res Clin Pract; 2018 Sep; 143():409-419. PubMed ID: 29807101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
    Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
    Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.